ArticleFrontiers in oncology2025

Sorafenib-to-regorafenib sequence-induced atherosclerotic cardiovascular disease: a novel case report.

Changli Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.